The Advanced Cancer Imaging division is interested in the development of imaging methods applied to cancer prevention, early detection of cancer, and monitoring the genetic and metabolic effects of treatment on cancer. We strive to find novel uses of existing imaging technology and work with small companies during their development of novel imaging and measurement devices. Our research spans basic imaging research in small animals and translational clinical trials in human subjects. Current projects include studies of the role of alcohol in the induction of breast cancer, novel contrast agents for tumor imaging, and the investigation of strategies for the early detection of lung, breast, and pancreas cancer. This program has close working relationships with the Lombardi Cancer Center , the visualization science group at Catholic University of America and the Advanced Research Institute of Virginia Technical University.

Division Director:  Matthew Freedman, MD, MBA